Mortality due to immunotherapy related hepatitis

J Hepatol. 2018 Oct;69(4):976-978. doi: 10.1016/j.jhep.2018.06.012. Epub 2018 Aug 6.

Authors

Prachi Bhave¹, Andrew Buckle², Shahneen Sandhu¹, Siddharth Sood³

Affiliations

¹ Peter MacCallum Cancer Centre, Melbourne, Australia.
² Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Gastroenterology & Hepatology, Royal Melbourne Hospital, Melbourne, Australia.
³ Department of Gastroenterology & Hepatology, Royal Melbourne Hospital, Melbourne, Australia. Electronic address: Siddharth.sood@mh.org.au.

PMID: 30093162
DOI: 10.1016/j.jhep.2018.06.012

No abstract available

Publication types

Letter
Comment

MeSH terms

Hepatitis*
Humans
Immunologic Factors
Immunotherapy
Neoplasms*

Substances

Immunologic Factors